• 1
    Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr. Bull. 2006; 32: 432442.
  • 2
    Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can. J. Psychiatry 2005; 50: 892900.
  • 3
    De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr. Res. 2007; 92: 6873.
  • 4
    Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2005; 162: 441449.
  • 5
    Ciudad A, Alvarez E, Bobes J, San L, Polavieja P, Gilaberte I. Remission in schizophrenia: results from a 1-year follow-up observational study. Schizophr. Res. 2009; 108: 214222.
  • 6
    Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr. Res. 2005; 77: 215227.
  • 7
    van Os J, Drukker M, à Campo J, Meijer J, Bak M, Delespaul P. Validation of remission criteria for schizophrenia. Am. J. Psychiatry 2006; 163: 20002002.
  • 8
    Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr. Res. 2007; 93: 160168.
  • 9
    Llorca PM, Lançon C, Lancrenon S et al. The ‘Functional Remission of General Schizophrenia’ (FROGS) scale: development and validation of a new questionnaire. Schizophr. Res. 2009; 113: 218225.
  • 10
    Kurihara T, Kato M, Reverger R, Tirta IGR, Kashima H. Never-treated patients with schizophrenia in the developing country of Bali. Schizophr. Res. 2005; 79: 307313.
  • 11
    World Bank. World Bank list of economies. 2011. [Cited 1 July 2011.] Available from URL: (last accessed 1 July 2011).
  • 12
    Endicott J, Andreasen NC, Spitzer RL. Family History-Research Diagnostic Criteria (FH-RDC), 3rd edn. New York State Psychiatric Institute, New York, 1978.
  • 13
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. revised, (DSM-III-R). APA, Washington, DC, 1987.
  • 14
    Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R (SCID). American Psychiatric Press, Washington, DC, 1990.
  • 15
    Kurihara T, Kato M, Reverger R, Yagi G. Clinical outcome of patients with schizophrenia without maintenance treatment in a non-industrialized society. Schizophr. Bull. 2002; 28: 515524.
  • 16
    Kay SR, Opler LA. Positive and Negative Syndrome Scale (PANSS) Rating Manual. Social and Behavioral Sciences Documents, San Rafael, CA, 1987.
  • 17
    Salan R, Budiman R, Bastaman TK et al. PANSS di Indonesia – validitas dan reliabilitas. In : Pedoman Definisi PANSS. Department of Neuropsychiatry, Faculty of Medicine, Indonesia University, Jakarta, 1994; (in Indonesian).
  • 18
    Ogawa K, Miya M, Watarai A, Nakazawa M, Yuasa S, Utena H. A long-term follow-up study of schizophrenia in Japan- with special reference to the course of social adjustment. Br. J. Psychiatry 1987; 151: 758765.
  • 19
    Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int. Rev. Psychiatry 2002; 14: 256272.
  • 20
    Bodén R, Sundström J, Lindström E, Lindström L. Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophr. Res. 2009; 107: 232237.
  • 21
    Lambert M, Schimmelmann BG, Naber D et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J. Clin. Psychiatry 2006; 67: 16901697.
  • 22
    Lambert M, Naber D, Schacht A et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr. Scand. 2008; 118: 220229.
  • 23
    Novick D, Haro JM, Suarez D, Vieta E, Naber D. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophr. Res. 2009; 108: 223230.
  • 24
    Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean? Schizophr. Res. 2005; 79: 231238.
  • 25
    Buckley PF, Harvey PD, Bowie CR, Loebel A. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr. Res. 2007; 94: 99106.
  • 26
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Int. Clin. Psychopharmacol. 2008; 23: 325331.
  • 27
    Kane JM, Crandall DT, Marcus RN et al. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophr. Res. 2007; 95: 143150.
  • 28
    Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr. Bull. 2008; 34: 229244.
  • 29
    Harrison G, Hopper K, Craig T et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br. J. Psychiatry 2001; 178: 506517.
  • 30
    Jablensky A, Sartorius N, Ernberg G et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol. Med. Monogr. Suppl. 1992; 20: 197.
  • 31
    World Health Organization. Schizophrenia: An International Follow-up Study. John Wiley and Sons, Chester, 1979.
  • 32
    Alem A, Kebede D, Fekadu A et al. Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia. Schizophr. Bull. 2009; 35: 646654.
  • 33
    San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur. Psychiatry 2007; 22: 490498.
  • 34
    Marwaha S, Johnson S, Bebbington P et al. Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br. J. Psychiatry 2007; 191: 3037.
  • 35
    Davidson L, Schmutte T, Dinzeo T, Andres-Hyman R. Remission and recovery in schizophrenia: practitioner and patient perspectives. Schizophr. Bull. 2008; 34: 58.
  • 36
    Simonsen E, Friis S, Haahr U et al. Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatr. Scand. 2007; 116: 5461.
  • 37
    Altamura AC, Bassetti R, Sassella F, Salvadori D, Mundo E. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophr. Res. 2001; 52: 2936.
  • 38
    Petersen L, Thorup A, Øqhlenschlaeger J et al. Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Can. J. Psychiatry 2008; 53: 660670.